Showing results (61-70 of 1,290) with videos related to
Sort By:
Pageof 129
Veterinary and Comparative Oncology|December 18, 2013
Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphomaA Poggi, B Miniscalco, E Morello, et al.Veterinary and Comparative Oncology|March 17, 2021
Response-based modification of CHOP chemotherapy for canine B-cell lymphomaSarah E Benjamin, Karin U Sorenmo, Erika L Krick, et al.Veterinary and Comparative Oncology|December 8, 2021
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006-2019)Julia Gedon, Alexandra Kehl, Heike Aupperle-Lellbach, et al.Veterinary and Comparative Oncology|September 2, 2022
Hypoxia-targeting therapy for intestinal T-cell lymphoma in dogs: Preclinical study using 3D in vitro modelsHiroki Yamazaki, Toshiyuki Tanaka, Hidetaka Nishida, et al.Veterinary and Comparative Oncology|September 3, 2022
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high-grade multicentric lymphomaSridhar Veluvolu, Jennifer L Willcox, Katherine A Skorupski, et al.Veterinary and Comparative Oncology|March 24, 2021
Ki-67 assessment-agreeability between immunohistochemistry and flow cytometry in canine lymphomaAntonella Rigillo, Andrea Fuchs-Baumgartinger, Silvia Sabattini, et al.Veterinary and Comparative Oncology|February 16, 2019
Tumour necrosis factor-related apoptosis-inducing ligand induces apoptosis in canine hemangiosarcoma cells in vitroMinami Goto, Keishi Owaki, Akihiro Hirata, et al.Veterinary and Comparative Oncology|February 12, 2021
Neutrophil-to-lymphocyte ratio is an independent prognostic marker for feline mammary carcinomasGonçalo N Petrucci, Luís Lobo, Felisbina Queiroga, et al.Veterinary and Comparative Oncology|February 8, 2017
Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi-institutional retrospective study of 64 casesB J Evans, D O'Brien, S D Allstadt, et al.Veterinary and Comparative Oncology|April 12, 2017
The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytomaAlexandra Keller, Bettina Wingelhofer, Barbara Peter, et al.Pageof 129